61 – 70 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
(
- Contribution to journal › Article
- 2017
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
-
Mark
Raynaud’s phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Mapping and predicting mortality from systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Quantitative outcome measures for systemic sclerosis-related Microangiopathy – Reliability of image acquisition in Nailfold Capillaroscopy
(
- Contribution to journal › Article
-
Mark
Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis : Analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening
(
- Contribution to journal › Article
-
Mark
Effects of intense pulsed light in microstomia in patients with systemic sclerosis : A pilot study
(
- Contribution to journal › Article